Itsik Pe'er is a Full Professor and Vice-Chair in the Department of Computer Science at Columbia University's Fu Foundation School of Engineering & Applied Science, and holds a joint appointment as Professor of Systems Biology at the Vagelos College of Physicians and Surgeons. His research focuses on computational methods in human genetics, including genetic variation analysis, disease association studies, and algorithm development for genomic data. He leads the Itsik Pe'er Lab of Computational Genomics, which develops tools like Xplorigin, Germline, and SEACells to address challenges in genomics and medical research. His work spans machine learning applications in healthcare, microbiome analysis, and cancer genomics. Notable contributions include studies on hypertensive disorders in pregnancy, bias correction in predictive models, and the development of non-Euclidean learning libraries like Manify. Pe'er has advised students including Vladimir Vacic, Anat Kreimer, and Arthi Ramachandran, and collaborates on grants addressing genetic epidemiology and computational biology. His lab's location is in the Computer Science Building at Columbia's Morningside Campus.
Tracey Evans Chan is an Associate Professor and Director of the NUS Law Academy at the National University of Singapore's Faculty of Law. His expertise lies in biomedical law and ethics, with a focus on issues such as surrogacy, transplant ethics, and human-animal research. He has held significant roles, including a secondment to Singapore's Ministry of Health, where he contributed to the Human Biomedical Research Act 2015. He currently serves on the National Medical Ethics Committee and the Advisory Committee on Restricted Research under the same Act, and is a member of NUS's Institutional Review Board. Education: LLM (Harvard University) LLB (National University of Singapore) Research Interests: Chan's work bridges legal and ethical dimensions of biomedical advancements. Key areas include regulatory challenges in mitochondrial replacement technology, consent frameworks for minors, and the ethical implications of emerging medical technologies. His contributions to Singapore's legal committees reflect his commitment to balancing innovation with societal values. Publications & Trends: His recent works explore themes like advance care planning, the placebo effect in clinical practice, and cross-jurisdictional comparisons of healthcare dependency laws. These publications underscore his interdisciplinary approach to legal and biomedical challenges. Awards & Grants: No specific awards or grants are listed, but his policy contributions and academic output highlight his impactful work in regulatory frameworks. Advising & Teams: As a faculty member, he teaches courses like Medical Law and Ethics. His involvement in NUS's Institutional Review Board and Singapore's advisory committees demonstrates his role in shaping research ethics and healthcare policy.
Dr. Yogambha Ramaswamy is a Senior Lecturer in the School of Biomedical Engineering at The University of Sydney and a member of the Sydney Nano Institute. She holds a Master’s in Biotechnology from the University of Queensland and a PhD in Biomedical Engineering from the University of Sydney (2009). Her postdoctoral career began as a Vice-Chancellor’s Postdoctoral Research Fellow at the University of New South Wales, followed by a Peter Doherty Early Career Fellowship in 2013 before joining the University of Sydney in 2015. Dr. Ramaswamy’s research focuses on biomaterials, tissue engineering, and mechanobiology, with a particular emphasis on developing calcium silicate-based ceramics and biopolymers for orthopedic and regenerative applications. Her recent work explores the role of physical cues in modulating stem and cancer cell behavior. She teaches courses such as AMME1961 (Introduction to Biomedical Engineering B) and AMME5962 (Introduction to Mechanobiology). Her research has been supported by grants including the NHMRC Early Career Fellowship and collaborations with institutions like the CSIR-Indian Institute of Chemical Technology and the University of Otago. Her publications span biomaterials, nanotechnology, and mechanobiology, with recent work addressing atherosclerosis, hydrogel design, and nanomedicine. She currently supervises PhD students Frank (biomaterials) and Alexander (atherosclerosis research).
Josiah Hester is Associate Professor of Interactive Computing and Computer Science at Georgia Tech's College of Computing, where he also directs the Center for Advancing Responsible Computing and the Ka Moamoa – Ubiquitous and Mobile Computing Lab . His research focuses on sustainable, battery-free computing systems for health, conservation, and education, informed by his Native Hawaiian heritage. Education: Ph.D. in Computer Science, Clemson University, 2017 B.S. in Computer Science, Clemson University Honors College, 2011 Research Interests: Hester’s group pioneers intermittent computing —devices that harvest ambient energy (solar, radio, thermal, microbial) and operate reliably despite frequent power loss. Applications span: Large-scale conservation sensing with Indigenous communities Battery-free health wearables (smart masks, implantables) Educational tools for sustainable design Carbon-aware IoT and recyclable robotics Recent Work & Trends: His 2024–2025 publications unveil soil-powered sensors, recyclable electronics, and culturally-grounded CS education tools. A consistent theme is co-design with underserved communities and embedding sustainability metrics at every layer—from hardware to curriculum. Scientific Awards: Presidential Early Career Award for Scientists and Engineers (PECASE) – 2025 Alfred P. Sloan Fellowship – 2022 NSF CAREER Award – 2022 Popular Science “Brilliant 10” – 2021 3M Non-Tenured Faculty Award – 2021 Multiple best-paper & best-presentation awards Grants & Teams: Hester’s lab is supported by >$50 million in active funding from NSF, NIH (ARPA-H), DARPA, DoD, Sloan, VMware, and 3M. He leads interdisciplinary teams on projects such as: $35 million ARPA-H bioelectronics initiative for diabetes and cancer $5 million NSF “Coastlines and People” Hub for Manoomin conservation $2 million NSF-DELPHI sustainable edge device design Laboratory & Mentorship: The Ka Moamoa Lab (named with Hawaiian meaning “lamp of the moamoa fish”) hosts graduate, undergraduate, and post-doctoral researchers. Hester actively recruits Native and Indigenous students and has mentored award-winning advisees such as Nivedita Arora (ACM Doctoral Dissertation Award 2024).
Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
Owen R. White is a Professor in the Department of Epidemiology & Public Health at the University of Maryland School of Medicine, serving as Associate Director of the Institute for Genome Sciences and Associate Director of Research Collaboration & Development. He leads a team of 25 scientists and engineers developing genomic annotation pipelines and data analysis tools for state-of-the-art research in microbiome and multi-omic studies. His academic background includes: BS in Biotechnology from the University of Massachusetts (1985) PhD in Molecular Biology from New Mexico State University (1992) Postdoctoral Fellowship in Genome Informatics at the Institute for Genomic Research (TIGR) (1994) Dr. White's research spans bioinformatics, genomics, transcriptomics, and metagenomics with emphasis on data management, metadata standards, ontologies, and cloud systems. His work has been foundational for large-scale initiatives like the Human Microbiome Project (HMP) and Integrative Human Microbiome Project (iHMP), generating over 50,000 datasets totaling 10 terabytes of multi-omic data. Analysis of his recent publications reveals a strong trend toward neuroscience multi-omics (BRAIN Initiative), cloud-based data infrastructure, and ethical data sharing frameworks. His work consistently bridges microbiome research with emerging fields like single-cell analysis and Alzheimer's disease biomarker discovery through integrated data platforms. Notable awards include: Benjamin Franklin Award for Open Access in the Life Sciences (2015) Kumho Science International Award in Plant Molecular Biology and Biotechnology (2001) As Principal Investigator for major NIH-funded centers, he has secured sustained support for the HMP Data Analysis and Coordination Center and iHMP Data Coordination Center. His team's work combines fee-for-service models with collaborative research funding to maintain cutting-edge genomic analysis capabilities. The Institute for Genome Sciences houses his computational team responsible for developing production annotation pipelines, database systems, and visualization tools that serve researchers across the University of Maryland School of Medicine and national consortia.
Dr. Daniel J. Preston is an Assistant Professor of Mechanical Engineering at Rice University, leading the Preston Innovation Laboratory (PI Lab). He holds a B.S. from the University of Alabama (2012), M.S. and Ph.D. from MIT (2014, 2017), and postdoctoral training at Harvard University (2017-2019). His research focuses on energy efficiency, soft materials, fluid mechanics, and robotics, with applications in wearable technologies and sustainable systems. Key achievements include the NSF CAREER Award (2022) and pioneering work on necrobotics using biotic materials. The PI Lab collaborates widely, with projects involving biomimetic surfaces, smart textiles, and fluidic control systems. Education: B.S. Mechanical Engineering, University of Alabama (2012) M.S./Ph.D. Mechanical Engineering, MIT (2014/2017) Research Interests: Energy : Thermal management, heat transfer optimization, and waste heat recovery. Materials : Soft actuators, surface coatings, and functional biomaterials. Fluids : Interfacial phenomena, droplet dynamics, and fluid-structure interactions. Notable Publications: Recent work includes advancements in wearable haptic devices ( Science Advances ), necrobotics ( Advanced Science ), and fluidic logic textiles ( PNAS ). Over 50 peer-reviewed articles span multidisciplinary topics from magnetic levitation to virus decontamination. Honors: In addition to the CAREER Award, Dr. Preston has received the NSF Graduate Research Fellowship, Tau Beta Pi Fellowship, and Wunsch Foundation Award. His lab fosters innovation through grants and industry partnerships. Advising & Grants: Supervises ~15 graduate and undergraduate students, including NSF GRFP recipients. Active in mentoring initiatives like the Randall Research Scholars Program and AATCC grants. Labs & Teams: The PI Lab collaborates with MIT’s DRL, Harvard’s Whitesides Group, and institutions globally. Core projects include smart wearables, energy harvesting fabrics, and autonomous soft robots.
Manuel R. Amieva is a Professor at Stanford University School of Medicine , holding joint appointments in Pediatrics - Infectious Diseases and Microbiology & Immunology . He is also a member of the Maternal & Child Health Research Institute (MCHRI) . His clinical practice at Stanford Medicine Children's Health focuses on pediatric infectious diseases. Education: Medical Education: Stanford University School of Medicine (1997) Fellowship: Stanford University Pediatric Infectious Disease Fellowship (2004) Internship & Residency: Stanford Health Care at Lucile Packard Children's Hospital (1998-1999) Dr. Amieva's research investigates host-pathogen interactions at epithelial barriers, with specific expertise in Helicobacter pylori , Listeria monocytogenes , Salmonella enterica , and Staphylococcus aureus . His lab develops innovative organoid culture systems with controlled polarity to study microbial colonization and oncogenic mechanisms. Key discoveries include: H. pylori's manipulation of epithelial junctions via the CagA protein Listeria's exploitation of cell extrusion sites for invasion Staphylococcus toxin interactions with adherens junctions Gastric stem cell activation by pathogens Recent publication trends show continued leadership in infectious disease mechanisms (2020-2025), with a focus on: Pathogen-specific epithelial breach strategies Organoid modeling of viral/bacterial interactions Redox-dependent host factor regulation Single-cell spatial transcriptomic analyses Multi-institutional educational frameworks His scientific collaborations span disciplines including: Gastric cancer genomics initiatives COVID-19 lung infection models Stem cell-microbe interactions Medical education reform projects Dr. Amieva maintains active clinical research while mentoring students in both the Microbiology & Immunology and Pediatrics programs. His lab at Stanford employs advanced 3D confocal microscopy and organ-on-a-chip technologies to visualize epithelial colonization dynamics.
Morteza Fayazi is an Assistant Professor in the Department of Electrical and Computer Engineering at the University of Utah, with an adjunct position in the Kahlert School of Computing. His research focuses on Electronic Design Automation (EDA), applying machine learning to automate analog and mixed-signal circuit design, and developing high-performance computing systems. He holds a B.Sc. from Sharif University of Technology, and M.S.E./Ph.D. degrees from the University of Michigan. His research interests include AI-driven EDA, RF/circuit automation, and energy-efficient processors. Key achievements include the MEDAL lab’s work on terahertz radars, systolic-array processors (e.g., DAP and Versa), and open-source frameworks like FASCINET and Tablext. He has received awards such as the 2024 College of Engineering Dean’s ETR Fund and the 2017 Outstanding Undergraduate Thesis Award. Teaching responsibilities include multiple iterations of the Digital System Design course (ECE/CS 3700). His work spans over 15 peer-reviewed articles in IEEE Transactions, ACM, and top conferences like ICCAD and VLSI-SOC, emphasizing automation, efficiency, and AI integration in hardware design.
Houman Savoji is an Associate Professor in the Department of Pharmacology and Physiology at the Faculty of Medicine, University of Montreal. He is also a full-time researcher at the CHU Sainte-Justine Research Center and principal investigator in regenerative medicine, organs-on-chip, and bioprinting at TransMedTech Institute. Dr. Savoji received his PhD in Biomedical Engineering from the Institute of Biomedical Engineering at Polytechnique Montréal in 2016. He then completed a postdoctoral fellowship at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. His research expertise combines advanced manufacturing technologies (micro- and nano-fabrication, 3D bioprinting, microfluidics, cell electrospinning) with functional and composite materials for applications in tissue engineering, regenerative medicine, and organs-on-chip. His work focuses on the design, development, optimization, implementation, and characterization of innovative functional biomaterials using emerging engineering technologies, with particular emphasis on cardiac tissue engineering and biomimetic pulmonary heart valves for pediatric patients. Dr. Savoji has published extensively on biomaterials, tissue engineering, 3D bioprinting, and organ-on-chip technologies. His recent publications demonstrate expertise in viscoelastic characterization of soft tissues, engineering immune responses to biomaterials, ceramic engineering for biomedical applications, and advanced 3D bioprinting techniques for cardiac and vascular tissue engineering. 2017-2020, Postdoctoral Research Grant, CIHR 2017-2019, Postdoctoral Research Grant, FRQNT 2017-2018, Human Society of International Grant, Human Toxicity Assessment Project 2016, CR-CHUM Research Center Award 2015, Star Student-Researcher Award, FRQNT 2014-2015, Jane and Frank Warchol Fellowship, Society of Vacuum Coaters Foundation 2013, Institute of Textile Science Award 2012-2015, Excellence Doctoral Scholarship for Foreign Students, FRQNT Dr. Savoji has supervised Master's students including Ines Barrakad (2024) working on 'Advanced manufacturing technologies versus molding of corneal implants: 3D printing vs molding of a Keratoprosthesis' and Zineb Ajji (2023) researching 'Development of perfusable patches by 3D bioprinting for potential application in cardiac tissue regeneration.' He has secured numerous research grants from organizations including CIHR, NSERC, FRQNT, FRQS, MITACS, and others for projects related to 3D bioprinting of cardiac tissues, biomimetic heart valves, and other tissue engineering applications. The Savoji Laboratory, located within the Department of Pharmacology and Physiology and Institute of Biomedical Engineering of the Faculty of Medicine of the University of Montreal, the Research Center of the CHU Sainte-Justine (CHUSJ), and the TransMedTech Institute, focuses on multidisciplinary research involving 3D bioprinting using stem-cell derived human cardiac cells to fabricate functional cardiac tissues for transplantation and drug discovery applications.
Professor Urs Jenal is a Full Professor at the Biozentrum of the University of Basel, Switzerland, where he has led research on bacterial signal transduction since 2008. His laboratory investigates the molecular mechanisms of bacterial persistence and antibiotic resistance, with particular focus on pathogens causing chronic infections in humans. Previously, he served as Associate Professor (2002-2008) and Assistant Professor (1996-2002) at the same institution, and completed postdoctoral training at Stanford University and ETH Zurich. Education 2000: Habilitation and VENIA DOCENDI in Microbiology, University of Basel 1987-1991: PhD in Molecular Microbiology, ETH Zurich (supervisor: Prof. T. Leisinger) 1982-1986: Studies of Experimental Biology, ETH Zurich 1977-1981: Gymnasium with Matura Type C, Chur Research Focus Prof. Jenal's research centers on understanding how bacterial pathogens persist in the human body despite antibiotic treatments. His laboratory investigates cyclic nucleotides, particularly c-di-GMP, as signaling molecules that control bacterial biofilm formation, virulence, and antibiotic tolerance. His team studies pathogenic Escherichia coli causing recurrent urinary tract infections and Pseudomonas aeruginosa causing long-term lung infections in cystic fibrosis patients. Recent work has revealed how "sleeping" bacteria survive antibiotic treatments and how pathogens breach respiratory epithelia through goblet cell invasion. Scientific Recognition 2014: Elected member of the European Academy of Microbiology (EAM) 2013: ERC Advanced Investigator Award 2012: Elected member of the European Molecular Biology Organization (EMBO) 2011: Elected member of the American Academy of Microbiology (AAM) Mentorship and Collaborations Prof. Jenal has mentored numerous PhD students and postdocs, many receiving awards for their research. His laboratory is part of the NCCR AntiResist initiative focused on developing novel approaches against antibiotic resistance. He collaborates extensively with clinical researchers and has developed innovative models, including human mini-lungs, to investigate pathogen-host interactions. His recent publications demonstrate how understanding bacterial persistence mechanisms can lead to new therapeutic strategies against chronic infections.
Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788
Qian Yang is an Assistant Professor in Information Science at Cornell University, with a faculty appointment in Computer Science. Her research focuses on human-AI interaction, designing AI applications for healthcare, autonomous systems, and UX design. She holds a PhD in Human-Computer Interaction from Carnegie Mellon University and has industry experience in design consultancy (2007–2014). Yang co-directs the Cornell Digital and AI Literacy Initiative and is a Senior Fellow at the Cornell Brooks Tech Policy Institute. Her work emphasizes bridging AI technologies with societal needs, supported by awards like the Schmidt Futures AI2050 Fellowship. She leads the DesignAI research group, focusing on AI-driven design methods and tools for practitioners. Education: PhD in HCI (Carnegie Mellon), M.S. in HCI (CMU), M.Des in Design, B.Eng in Industrial Design (Shanghai Jiao Tong University). Research interests include AI ethics, healthcare decision support systems, and context-aware mobile services. Notable contributions include: Developing AI systems for life-critical healthcare decisions (e.g., artificial heart implants) Innovating UX design methods for integrating AI into practice Advancing human-centered AI evaluation frameworks Awards include the SIGCHI Outstanding Dissertation Award and AI2050 Fellowship. She actively collaborates across disciplines, with work published in top HCI venues like CHI and ACM Transactions.
Ron Dror is the Cheriton Family Professor of Computer Science at the Stanford Artificial Intelligence Lab , with courtesy appointments in Structural Biology and Molecular & Cellular Physiology . He also holds affiliations with Bio-X, the Institute for Human-Centered Artificial Intelligence (HAI), the Institute for Computational and Mathematical Engineering (ICME), Sarafan ChEM-H, and the Wu Tsai Neurosciences Institute. Education: PhD in Electrical Engineering and Computer Science, MIT MPhil in Biological Sciences, University of Cambridge (Churchill Scholar) BS in Mathematics and Electrical & Computer Engineering, Rice University (summa cum laude) Ron leads a multidisciplinary research group that combines molecular simulation and machine learning to study biomolecular structure, dynamics, and function. His work focuses on developing computational methods to accelerate drug discovery by predicting molecular interactions and designing more effective therapeutics. Current projects include the PENSA software library for analyzing biomolecular ensembles and FRAME framework for structure-based ligand design. His research has produced groundbreaking work on G-protein-coupled receptors (GPCRs) , RNA structure prediction , and mitochondrial transport mechanisms . Key publications highlight applications of geometric deep learning and molecular dynamics simulations in structural biology. Scientific Awards: Cheriton Family Professorship (2023) Two Gordon Bell Prizes (2014, 2009) Best Paper Awards at NeurIPS (2021), IPDPS (2013), SC11 (2011), SC09 (2009), SC06 (2006) Science Magazine Top 10 Breakthrough (2010) Fulbright Scholarship , NSF Fellowship , DoD Fellowship , Whitaker Foundation Fellowship Ron has advised numerous doctoral and master’s students including EJ Fine , Masha Karelina , and Briana Sobecks . His lab collaborates with experimentalists across academia and industry, applying computational methods to diverse biomedical problems such as RNA structure prediction , GPCR signaling , and mitochondrial metabolism .
Dr. Jarno Hoekman is an Associate Professor in Innovation Studies at the Copernicus Institute of Sustainable Development, Utrecht University. His research focuses on the dynamics and governance of science in the context of innovation, regulation, and societal challenges, with particular emphasis on sustainability and health. He is affiliated with both the Copernicus Institute of Sustainable Development and the Utrecht collaborating Centre for Pharmaceutical Policy & Regulation in the Department of Pharmaceutical Sciences. Dr. Hoekman serves as the programme leader of the research master in Innovation Sciences and teaches academic integrity courses to Master students and PhD candidates. Dr. Hoekman's research is organized around three interconnected themes: Science in transition , examining how scientific practices and institutional arrangements are evolving through open science, interdisciplinary research collaborations, and alternative recognition systems; Regulatory science and innovation , investigating innovations in tools and standards for assessing risks and benefits of new technologies, including safety assessment methods and regulatory authorization standards; and Geography of science , exploring the role of location factors in scientific knowledge production and diffusion. Analysis of Dr. Hoekman's recent publications (2022-2024) reveals a strong interdisciplinary focus spanning pharmacology, toxicology, innovation studies, and science policy. Key research trends include examining conditional marketing authorization pathways, post-approval studies for conditionally authorized medicines, animal-free safety testing methodologies, and the societal impact of transdisciplinary research projects. His work frequently employs mixed-methods approaches and involves multi-stakeholder perspectives to address complex regulatory and innovation challenges. Dr. Hoekman actively contributes to policy-relevant research, including major European Commission studies on pharmaceutical legislation. His collaborative work extends across multiple institutions and involves interdisciplinary teams working on pharmaceutical policy, sustainable innovation, and science-society interactions. As a member of the Utrecht Young Academy and the UU Open Science Platform, he engages with broader academic community initiatives related to research integrity and open science practices.
